Company intelligence / Profile preview

Global Biotechnologies

Portland, Maine, United Statesglobalbio.com ↗

Ownership: Private
Development stage: Commercial

Overview

Global Biotechnologies is a commercial-stage manufacturer specializing in infection control products such as antimicrobial skin care solutions, hard surface disinfectants, immune system support supplements for vulnerable populations, contaminant removal systems for foods and industrial use, toxic gas removal products, and health-related pet products. Their offerings are FDA/EPA registered where applicable.

Therapeutic areas: OtherImmunologyInfectious Diseases
Modalities: Small moleculeProteinBiologicDeviceNutraceuticalsChemical
Industry: Non-Drug Biotech

Drug pipeline

2 assets

Microsan Anti-Microbial Foaming Hand Sanitizer

Commercial

Indications: Infection prevention

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Global Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Global Biotechnologies.

Explore the full profile